Tag Archives: series c

Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs

Ten months ago Randy Schatzman was appointed CEO of cancer drug developer Bolt Biotherapeutics, and tasked with getting its first drug candidate into the clinic, building out its C-suite, and raising more money. On Wednesday Schatzman checked the last box on that priority list, closing a $93.5 million Series C financing round from a group […]

Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round

[Updated 4/23/19 9:10 a.m. See below.] The race to bring CAR-T cell therapy to multiple myeloma, a persistent and deadly cancer of the bone marrow, continued on Monday with a fresh round of funding for Poseida Therapeutics. Swiss pharma giant Novartis has invested $75 million in a $142 million Series C round for San Diego-based […]

Posted in National blog main, San Diego, San Diego blog main, San Diego top stories | Tagged Aisling Capital, Biotech, BlueBird Bio, Boxer Capital, cancer, CAR-T, Cell Therapy, clinical trials, Drug Development, Eric Ostertag, Financing, funding round, fundraising, Gene Therapy, Life Sciences, Longitude Capital, Malin, Millennium, orphan disease, Pentwater Capital, Perceptive Advisors, Poseida Therapeutics, SanDiegoVC, series c, Tavistock Group, Venture Capital, Vivo Capital | Comments Off

VC Trends in 2019: More Money, Fewer Deals But Women Still Get Less

[Updated 11:23 a.m. See below.] If you’ve been following venture capital trends, what you expected to happen in the first quarter of 2019 did: More money is being invested in fewer deals, and women founders still are getting less of it than men. Venture firms sent $32.6 billion into startups nationally during the first three […]

Posted in Boston blog main, Detroit blog main, Detroit top stories, Indiana blog main, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, San Francisco top stories, Seattle blog main, Texas blog main, Texas top stories, Wisconsin blog main | Tagged angel, Automation Anywhere, Biotech, Bright Machines, CB Insights, deal count, deals, Devoted Health, Early Stage, Entrepreneurship, Epic Games, FAIR, Faraday Future, Financings, Flexport, funding, funding rounds, Hardware, Innotech, Instacart, Juul, Katerra, late-stage, Life Sciences, Lyft, Magic Leap, Material Sciences, mega funding, mega-round, MoneyTree, MoneyTreey, National Venture Capital Association, National Venture Capital Ssociation, Nuro, NVCA, Physics, PitchBook, PricewaterhouseCoopers, Prototype, PwC, quantum computers, Quantum Computing, quantum computing software, Relay Therapeutics, SanFranciscoVC, Series A, Series B, series c, Series D, Snowflake, Softbank, Software, startups, Strangeworks, Tech, The We Company, Uber, VC, venture, Venture Capital, Venture Funding, venture investment, Venture Monitor, WeWork, Whurley, William Hurley, women, women founders | Comments Off

Prognos Adds $20.5M for A.I. That Aims to Diagnose Diseases Earlier

This year, money has been funneling into companies that apply artificial intelligence to healthcare, from diagnostics to speech recognition software. The latest recipient is New York-based Prognos, which says it just closed a $20.5 million Series C round from a group of prominent insurers, drug makers, and venture capital investors. Prognos’s A.I.-related software aims to […]

Posted in Boston blog main, National blog main, New York, New York blog main, New York top stories | Tagged A.I., AI, algorithm, Algorithms, Artificial Intelligence, Cigna, deep learning, diagnosis, diagnostic, drug, Drug Development, funding, GIS Strategic Ventures, Guardian Life Insurance, health, health care, healthcare, Hermed Alpha Industrial, Hikma Pharmaceuticals, Hikma Ventures, IBM, Illumina, insurance, insurer, Life Science, Life Sciences, Machine Learning, Maywic Select Investments, Merck Global Health Innovation Fund, Microsoft, NewYorkVC, payer, payers, Prognos, Safeguard Scientific, series c, Thermo Fisher Scientific, VC, Venture Capital, Venture Funding | Comments Off

GNS Healthcare Adds $6M, Led by Amgen, for Machine Learning Tech

The investment arm of biotech giant Amgen has led a new $6 million round of funding in GNS Healthcare, CEO Colin Hill tells Xconomy. Amgen Ventures’ new investment is a part of the company’s Series C financing round, which now totals $23 million, says Hill, who is also GNS’s chairman and co-founder. Cambridge, MA-based GNS […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories, New York blog main | Tagged Alexandria Real Estate Equities, Amgen, Atomwise, Berg Pharma, big data, BostonVC, Celgene, Colin Hill, Cornell, Data Analytics, drug discovery, Fort Rock Capital, Gene Network Sciences, GHO Capital, GNS Healthcare, Healthtech, Heritage Provider Network, Horizon Blue Cross of NJ, Iya Khalil, licensing, Life Sciences, Machine Learning, Mitsui, Precision Medicine, Qrativ, REFS, Regence Blue Cross Blue Shield (Cambia Health Solutions), Reverse Engineering & Forward Simulation, series c, Software, startups, Tech, VC, Zambon Pharma | Comments Off

With Ransomware Concerns Fresh, Cybersecurity Firms Tap VC Funding

While a wave of cyber attacks like the coordinated “WannaCry” virus may be bad for business, it’s no secret that it means good business promotion for the cybersecurity industry. As cybersecurity stocks rose across the board Monday after a weekend full of hacks, a variety of startups rode the wave of interest in Web security […]

Posted in Detroit blog main, Detroit top stories, National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged 83North, Accel, AI, algorithm, Algorithms, Artificial Intelligence, automotive cybersecurity, autonomous, autonomous cars, Bessemer Venture Partners, CapitalG, Computer Networks, Conjur, Connected Cars, CrowdStrike, cyber, Cyber Attack, Cyber Security, CyberArk Software, Cybersecurity, endpoint security, equity, Financing, Google Capital, hackers, Hacking, internet piracy, Internet Security, Karamba, Machine Learning, Mi:RIAM, mobile cybersecurity, Mobile Security, ransomware, SanFranciscoVC, Sapphire Ventures, Security, Self-Driving Cars, series c, SFVC, SLocker, Startup, startups, VC, Venture Capital, venture dept, venture financing, Venture Funding, Wandera, WannCry, Warburg Pincus | Comments Off

Governments Pay for Research, Jobs in San Antonio Tech and Science

San Antonio — Finding funding for tech and life science ventures is no easy endeavor, be it an academic setting or in the corporate world. Government groups in Texas announced this week that they’re providing money to both sectors in San Antonio to boost research and job growth. The Cancer Prevention and Research Institute of Texas […]

Posted in National blog main, Texas, Texas blog main, Texas top stories | Tagged Amasia Capital, Andreessen Horowitz, Bexar County, Biotech, cancer, Cancer Prevention and Research Institute of Texas, Cancer Research, Center for Innovative Drug Discovery, chemical compound, CIDD, cloud, cloud-based communication, CPRIT, Dialpad, Drug Development, Easyexpunctions.com, exome, expunction, Felicis Ventures, Geekdom, Google Ventures, Health Science Center, high through-put screnning, Life Science, Life Sciences, Matt Hart, medical chemistry, non-disclosure, Pfizer, protein, San Antonio, series c, small molecule, Softbank, Stanton McHardy, switch.co, Tech, University of Texas at San Antonio, University of Texas Health Science Center at San Antonio, UT Health Science Center, UT Health Science Center at San Antonio, Work-Bench | Comments Off

Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates

Austin—Savara Pharmaceuticals, a privately held drug developer with an inhaled formulation of an antibiotic for a type of lung infection, is announcing today that it is acquiring two new drug programs. The Austin, TX-based company also is seeking new funding that could precede an initial public offering. “Now that we have multiple products in the […]

Posted in National blog main, Texas, Texas blog main, Texas top stories | Tagged AeroVanc, Biotech, Clinical Trial, Cystic Fibrosis, Cystic Fibrosis Foundation, Denmark, ech Coast Angels, EU, europe, exome, funding, generic, generic drug, inhaled, inhaled drug, intravenous adminstration, intravenous therapy, Japan, Keiretsu Forum, Life Science, Life Sciences, methicillin-resistant Staphylococcus aureus, mezzanine round, Molgradex, MRSA, National Institutes of Health, North Texas Angel Network, PAP, pharma, phase 2, Phase 2 trial, Phase 3, phase 3 trial, pseudmonas aeruginosa, pulmonary alveolar Proteinosis, rare disease, rare disorder, Rob Neville, Savara Pharmaceuticals, Serendex, Series B, series c, Taneli Jouhikainen, Texas Emerging Technology Fund, Texas VC, TexasVC, the Central Texas Angel Network, Vancomycin, VC, Venture Capital, venture financing, Venture Funding | Comments Off

OutboundEngine Gets $16M for Marketing Software for Small Businesses

Austin—OutboundEngine, an Austin, TX-based company that makes business development software, has raised $16 million in Series C funding. The round was led by S3 Ventures, with participation from Silverton Partners, Noro-Moseley, Harmony Partners, Altos Ventures, and Capital Factory. The company says it will use the money to hire additional software developers, as well as marketing […]

Posted in National blog main, Texas, Texas blog main, Texas top stories | Tagged Altos Ventures, austin, Branndon Stewart, Business Development, Capital Factory, funding, Harmony Partners, marketing, Noro-Moseley, OutboundEngine, S3 Ventures, series c, Silverton Partners, Small Businesses, Software, Venture Capital | Comments Off

Maxwell Health Gets $22M More to Simplify Health Benefits

Veer Gidwaney admits that he and his brother were probably a “little bit naïve” about the complexity of the healthcare industry when they started up Maxwell Health in 2012. Their startup provides Web-based software for buying and managing health insurance plans and other benefits, and runs an online marketplace for other human resources and health-related […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, New York blog main, New York top stories | Tagged Adams Street Partners, benefits, Cambia Health Solutions, Catalyst Health Ventures, Cendana Capital, GIS Strategic Ventures, Health Insurance, HR, ID Watchdog, Industry Ventures, Kashable, Lerer Hippeau Ventures, Life Sciences, Maxwell Health, Schooner Capital, series c, Software, startups, Sun Life Financial, Tech, The Guardian Life Insurance Company of America, Tribeca Venture Partners, Vaizra Investments, VC | Comments Off← Older posts

Tag Archives: series c

Archives

Meta